López López José Carlos, Fernández Alonso Nieves, Cuevas Álvarez Juan, García-Caballero Tomás, Pastor Jimeno José Carlos
Ocular Pathology Laboratory, Instituto Universitario de Oftalmobiología Aplicada (IOBA), University of Valladolid, Valladolid, Spain,
Department of Pathology, Hospital Clínico Universitario, Santiago de Compostela, Spain.
Clin Ophthalmol. 2018 Jun 28;12:1171-1179. doi: 10.2147/OPTH.S141503. eCollection 2018.
We evaluated the expression of the neural markers, neuron-specific enolase, and synaptophysin, as a tool to confirm the diagnosis of retinoblastoma (RB) in undifferentiated and advanced tumors. Additionally, we determined whether the extent of RB-associated protein (pRb) expression is helpful in assessing the prognosis in RB patients.
Conventional whole tissue section and tissue microarray immunohistochemistry for neuron-specific enolase, synaptophysin, and pRb were carried out in a series of 22 RBs.
Neuron-specific enolase and synaptophysin were expressed in 75%-100% of the tumor cells, and the staining intensity was strong. Two RBs expressed pRb in 75%-100% of the tumor cells, also with strong staining intensity. Concordance between the immunohistochemical outcomes for whole tissue staining and tissue microarray staining was 76.2% for neuron-specific enolase, 85.7% for synaptophysin, and 80.0% for pRb.
Neuron-specific enolase and synaptophysin have the potential to be useful markers for the diagnosis of RBs. Extensive and strong pRb staining is not associated with less aggressive tumor behavior according to the pathologic classification of RBs.
我们评估了神经标志物神经元特异性烯醇化酶和突触素的表达,作为确诊未分化和晚期视网膜母细胞瘤(RB)的一种手段。此外,我们确定RB相关蛋白(pRb)的表达程度是否有助于评估RB患者的预后。
对一系列22例RB进行常规全组织切片和组织芯片免疫组化检测,以检测神经元特异性烯醇化酶、突触素和pRb。
75%-100%的肿瘤细胞表达神经元特异性烯醇化酶和突触素,染色强度强。2例RB中75%-100%的肿瘤细胞表达pRb,染色强度也很强。全组织染色和组织芯片染色的免疫组化结果之间,神经元特异性烯醇化酶的一致性为76.2%,突触素为85.7%,pRb为80.0%。
神经元特异性烯醇化酶和突触素有可能成为诊断RB的有用标志物。根据RB的病理分类,广泛且强烈的pRb染色与肿瘤侵袭性较低无关。